Co-Diagnostics Joint Venture CoSara provides Ebola Test Kits for analytical studies

Co-Diagnostics, Inc., a US-based molecular diagnostics company with a unique, patented platform for the development of m...

July 28, 2026 | Tuesday | News
Japan's GHIT Fund injects approx. JPY 140 M in portable rapid diagnostic system for Ebola Disease

Japan's Global Health Innovative Technology (GHIT) Fund has announced an investment of JPY 140 million (approximately $8...

July 24, 2026 | Friday | News
Malaysia approves MTB Nucleic Acid Test Card to aid in pulmonary TB diagnosis

As Malaysia confronts a significant surge in Tuberculosis (TB) cases, with over 3,100 confirmed infections recorded in t...

July 22, 2026 | Wednesday | News
M42 joins hands with Abbott to advance early cancer detection capabilities in UAE

M42’s National Reference Laboratory (NRL), a leading provider of diagnostic services in the region, has entered in...

July 23, 2026 | Thursday | News
Beyond Off-the-Shelf: Rethinking Manufacturing for the Next Generation of Cell and Gene Therapies

    The next generation of cell and gene therapies is pushing manufacturing beyond the limits of conventiona...

July 21, 2026 | Tuesday | Influencers
Korea's Seegene receives US FDA Emergency Use Authorisation for Multiplex PCR Assay

South Korea-based Seegene, Inc., a global leader in molecular diagnostics, has announced that its US subsidiary, Seegene...

July 22, 2026 | Wednesday | News
Taiwan’s Regenerative Medicine Rise Is Redefining the Rules of Cell Therapy

Cell therapy is approaching a defining transition: from highly specialised science to a reproducible, scalable pharmaceu...

July 16, 2026 | Thursday | Influencers
Virax Biolabs inks commercial supply agreement with Fosun Diagnostics covering six Southeast Asian markets

Virax Biolabs has announced that its wholly owned subsidiary, Virax Biolabs (UK) has entered into an exclusive multi-cou...

July 10, 2026 | Friday | News
Seegene's global clinical study for shaping disease-specific testing standards to begin in Korea

Seegene has announced the launch of the Global Million Clinical Study (GMCS), aiming to evaluate the clinical utility an...

July 8, 2026 | Wednesday | News
The Manufacturing Shift Powering In Vivo Gene Therapy

The rapid expansion of in vivo gene therapy is reshaping expectations for viral vector manufacturing, placing greater em...

July 5, 2026 | Sunday | Influencers
How Testing is Reshaping Front Door of Care in Thailand

Thailand is entering a diagnostics renaissance, shifting from illness confirmation within hospitals to early diagnosis t...

July 1, 2026 | Wednesday | Opinion
Evolving Diagnostics Landscape in APAC

Having worked across the Asia-Pacific (APAC) region in molecular diagnostics, I am often asked which country is ‘w...

July 1, 2026 | Wednesday | Opinion
Going Local: The New APAC Diagnostics Playbook

Diagnostics has become one of the fastest-evolving segments of healthcare in Asia-Pacific. For decades, the region's dia...

July 1, 2026 | Wednesday | Analysis
Better Diagnostics Could Save More Lives Than the Next Breakthrough Antifungal

Despite causing millions of serious infections and hundreds of thousands of deaths each year, fungal diseases continue t...

June 25, 2026 | Thursday | Influencers
First PMDA-approved molecular residual disease (MRD) test enters Japan

US-based Natera, Inc., a global leader in cell-free DNA and precision medicine, has announced that Signatera has re...

June 24, 2026 | Wednesday | News
The Future of HIV Care Will Be Defined by Flexibility, Not Just Longer Dosing Intervals

Few therapeutic areas have witnessed the level of progress achieved in HIV over the past three decades...

June 24, 2026 | Wednesday | Influencers
Why the Fight Against Antimicrobial Resistance Must Include Fungal Infections

While antimicrobial resistance (AMR) is often overshadowed by high-profile therapeutic areas such as oncology, its growi...

June 23, 2026 | Tuesday | Influencers
The Future of Eye Care Lies in Treating Inflammation at Its Source

Autoimmune and inflammatory diseases frequently affect the eye, yet ophthalmology has largely remained on the sidelines ...

June 23, 2026 | Tuesday | Influencers
Breaking the Pain-Safety Trade-Off: The Promise of Dual NOP/MOP Agonists

The search for safer and more effective pain therapies remains one of medicine's most pressing challenges. Despite advan...

June 23, 2026 | Tuesday | News
Infectious Diseases Reference Lab in Abu Dhabi joins WHO global network to monitor measles and rubella

In a step that reflects Abu Dhabi’s growing contribution to global health security, the Abu Dhabi Public Health Ce...

June 17, 2026 | Wednesday | News
Waters announces US FDA 510(k) clearance of BD BACTEC FXI Culture System

Waters Corporation has announced that the BD BACTEC FXI Culture System has received US Food and Drug Administr...

June 4, 2026 | Thursday | News
Korea-based 3billion launches new genomic newborn screening service 3B-NEO

3billion, a South Korea-based AI-powered genomic diagnostics company, has announced the launch of 3B-NEO, a premium...

June 2, 2026 | Tuesday | News
Australian medtech startup Oli secures $6.5 M to advance predictive maternal and foetal monitoring

Oli, a wireless, wearable device that monitors maternal and fetal signals, has secured $6.5 million in funding to accele...

May 27, 2026 | Wednesday | News
Inbiomotion brings MAF Test® for breast cancer prognosis in South Korea

HJ HyupJin, a South Korean healthcare and precision diagnostics company, and Inbiomotion, proprietors of MAF Test® f...

May 26, 2026 | Tuesday | News
AMR innovation faces growing investment gap despite rising global health threat

Antimicrobial resistance (AMR) continues to be recognised as one of the world’s most pressing ...

May 14, 2026 | Thursday | Opinion